New Biologics in PsA | myCME

AMA PRA Category 1 Credit(s)^TM

Hear expert insights on when to use interleukin inhibitors in the course of psoriatic arthritis.

R.A.P.I.D. Interstitial Lung Disease Case Study | myCME

AMA PRA Category 1 Credit(s)^TM

The R.A.P.I.D.® CME initiative is designed to instruct primary care clinicians in to recognizing and managing rheumatoid arthritis (RA) in their patients.

Voices in Psoriatic Arthritis

AMA PRA Category 1 Credit(s)^TM

This is a 45-minute online activity featuring expert presentations and audio clips of patient perceptions to customize treatment for patients with psoriatic arthritis.

Adopting a Tailored Approach to Managing Unmet Needs in Osteoarthritis | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

This CME Outfitters Snack focuses on recognizing the complex pathogenesis of OA, applying The Osteoarthritis Research Society International (OARSI) guidelines to non-surgical management, and evaluating emerging data in order to set realistic goals with patients and meet unmet needs in the management of OA.

Adapting and Adjusting: Best Practices for Utilizing Telehealth in Osteoarthritis Management | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

The final installment in this CME Outfitters Snack series on managing OA focuses on best practices for utilizing telehealth, including encouraging patients to maximize mobility in time of isolation, increasing the utilization of video in telehealth and wearable tech, and the consideration of both operative and non-operative measures for treatment.

PsA + COVID-19: Connecting on Patient Care During a Pandemic | myCME

AMA PRA Category 1 Credit(s)^TM

COVID-19 has made providing care to patients with psoriasis and psoriatic arthritis (PsA) more uncertain and complex. This 30-minute online activity is presented by the nationally and internationally recognized rheumatology expert who will review recommendations relevant to treatment of PsA by American College of Rheumatology, National Psoriasis Foundation, Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, and European League Against Rheumatism.

A Closer Look at Evolving Treatment Strategies for Rheumatoid Arthritis | myCME

AMA PRA Category 1 Credit(s)^TM

Hear a lively discussion of the latest RA treatment trends, tips for patient-centered care, and expert insights on the newest data.

Seeing Osteoarthritis Management Through a New Mechanistic Lens | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

The second installment of this CME Outfitters Snack series on improving care and outcomes in OA will evaluate emerging treatments in order to address the unmet needs of current OA therapies.

Utilizing Serological Biomarkers in Assessing the Disease Severity of Rheumatoid Arthritis | myCME

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s), CE for Pharmacists

Educate clinicians who care for patients with RA on the use of serological biomarkers and the guideline-driven assessment of disease severity to determine the appropriate course of disease management.

Immune Pathways in Systemic Lupus Erythematosus (SLE) | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

The first episode of this CMEOCast podcast series on systemic lupus erythematosus (SLE) focuses on the heterogeneity of lupus, including the multiple immune pathways that are active in it and how knowledge of immunopathogenesis has informed drug development.

Safety and Efficacy of Emerging Treatments for SLE | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

The future is bright for patients with lupus, as drug development activities are currently unprecedented. In this CMEOCast podcast episode, expert faculty evaluate the safety and efficacy of emerging therapies.

Shared Decision-Making in the Selection of SLE Treatments | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

The final episode in this CMEOCast podcast series on SLE addresses the impact and burden of SLE on quality of life, the integration of PROs when caring for patients with SLE, and the implementation of best practices for SDM in order to engage patients as partners in their care.